Results 11 to 20 of about 40,748 (225)

ER stress-induced eIF2-alpha phosphorylation underlies sensitivity of striatal neurons to pathogenic huntingtin. [PDF]

open access: yesPLoS ONE, 2014
A hallmark of Huntington's disease is the pronounced sensitivity of striatal neurons to polyglutamine-expanded huntingtin expression. Here we show that cultured striatal cells and murine brain striatum have remarkably low levels of phosphorylation of ...
Julia Leitman   +6 more
doaj   +15 more sources

The Ubiquitin-Proteasome Pathway in Huntington's Disease [PDF]

open access: yesThe Scientific World Journal, 2008
The accumulation of mutant protein is a common feature of neurodegenerative disease. In Huntington's disease, a polyglutamine expansion in the huntingtin protein triggers neuronal toxicity.
Siddhartha Mitra, Steven Finkbeiner
doaj   +3 more sources

Tissue Transglutaminase Selectively Modifies Proteins Associated with Truncated Mutant Huntingtin in Intact Cells

open access: yesNeurobiology of Disease, 2001
The cause of Huntington's disease (HD) is a pathological expansion of the polyglutamine domain within the N-terminal region of huntingtin. Neuronal intranuclear inclusions and cytoplasmic aggregates composed of the mutant huntingtin within certain ...
Wanjoo Chun   +2 more
exaly   +3 more sources

Huntingtin and the Synapse [PDF]

open access: yesFrontiers in Cellular Neuroscience, 2021
Huntington disease (HD) is a monogenic disease that results in a combination of motor, psychiatric and cognitive symptoms. HD is caused by a CAG trinucleotide repeat expansion in the huntingtin (HTT) gene, which results in the production of a pathogenic mutant HTT protein (mHTT).
Barron, Jessica C.   +2 more
openaire   +4 more sources

Full-length huntingtin is palmitoylated at multiple sites and post-translationally myristoylated following caspase-cleavage

open access: yesFrontiers in Physiology, 2023
Introduction: Huntington disease is an autosomal dominant neurodegenerative disorder which is caused by a CAG repeat expansion in the HTT gene that codes for an elongated polyglutamine tract in the huntingtin (HTT) protein.
Fanny L. Lemarié   +4 more
doaj   +1 more source

The Biology of Huntingtin [PDF]

open access: yesNeuron, 2016
Huntingtin (HTT) is now a famous protein because an abnormal expansion of a glutamine stretch (polyQ) in its N-terminal sequence leads to the devastating neurodegenerative disorder Huntington's disease (HD). The gene encoding huntingtin, HTT, and its dominantly inherited mutation were identified more than 20 years ago.
Saudou, Frédéric, Humbert, Sandrine
openaire   +2 more sources

Thermodynamics of Huntingtin Aggregation [PDF]

open access: yesBiophysical Journal, 2020
Amyloid aggregates are found in many neurodegenerative diseases, including Huntington's, Alzheimer's, and prion diseases. The precise role of the aggregates in disease progression has been difficult to elucidate because of the diversity of aggregated states they can adopt.
Tam T M, Phan, Jeremy D, Schmit
openaire   +2 more sources

The evolution of the huntingtin-associated protein 40 (HAP40) in conjunction with huntingtin [PDF]

open access: yesBMC Evolutionary Biology, 2020
AbstractBackgroundThe huntingtin-associated protein 40 (HAP40) abundantly interacts with huntingtin (HTT), the protein that is altered in Huntington’s disease (HD). Therefore, we analysed the evolution of HAP40 and its interaction with HTT.ResultsWe found that in amniotes HAP40 is encoded by a single-exon gene, whereas in all other organisms it is ...
Manuel Seefelder   +8 more
openaire   +8 more sources

IKBKB reduces huntingtin aggregation by phosphorylating serine 13 via a non-canonical IKK pathway

open access: yesLife Science Alliance, 2023
Early exposure of RA induced altered expressions of Wnt-related genes and subsequent osteogenic differentiation in embryonic mouse craniofacial prominences in a spatiotemporal-dependent manner.
Cristina Cariulo   +7 more
doaj   +1 more source

Huntingtin Lowering Strategies [PDF]

open access: yesInternational Journal of Molecular Sciences, 2020
Trials using antisense oligonucleotide technology to lower Huntingtin levels in Huntington’s disease (HD) are currently ongoing. This progress, taking place only 27 years after the identification of the Huntingtin gene (HTT) in 1993 reflects the enormous development in genetic engineering in the last decades.
Franz Marxreiter   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy